Point72 Asia Singapore Pte. Ltd. reduced its stake in MultiPlan Co. (NYSE:MPLN - Free Report) by 71.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,916 shares of the company's stock after selling 14,740 shares during the period. Point72 Asia Singapore Pte. Ltd.'s holdings in MultiPlan were worth $87,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in MPLN. Millennium Management LLC boosted its holdings in shares of MultiPlan by 43.1% during the fourth quarter. Millennium Management LLC now owns 152,785 shares of the company's stock valued at $2,258,000 after acquiring an additional 46,002 shares during the period. CastleKnight Management LP bought a new stake in MultiPlan in the 4th quarter valued at about $3,314,000. Bridgeway Capital Management LLC lifted its position in MultiPlan by 73.1% in the 4th quarter. Bridgeway Capital Management LLC now owns 76,193 shares of the company's stock valued at $1,126,000 after purchasing an additional 32,187 shares during the last quarter. Ares Management LLC boosted its stake in MultiPlan by 19.2% during the 4th quarter. Ares Management LLC now owns 893,738 shares of the company's stock valued at $13,209,000 after purchasing an additional 144,000 shares during the period. Finally, Jane Street Group LLC grew its position in MultiPlan by 14.4% in the 4th quarter. Jane Street Group LLC now owns 19,985 shares of the company's stock worth $295,000 after purchasing an additional 2,512 shares during the last quarter. 87.15% of the stock is owned by institutional investors.
MultiPlan Stock Performance
Shares of NYSE:MPLN traded up $0.06 during trading hours on Friday, hitting $28.78. The stock had a trading volume of 55,468 shares, compared to its average volume of 118,510. The stock's fifty day simple moving average is $21.78 and its 200 day simple moving average is $17.10. The firm has a market capitalization of $465.40 million, a price-to-earnings ratio of -0.30 and a beta of 0.13. The company has a debt-to-equity ratio of 21.73, a quick ratio of 1.05 and a current ratio of 1.05. MultiPlan Co. has a 1-year low of $4.80 and a 1-year high of $29.84.
MultiPlan Company Profile
(
Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Featured Stories
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
